Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.43 |
| ▸ | PTPRC | P08575 | 1/20 | 0.43 |
| ▸ | S100A4 | P26447 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.41 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3979945 | 0.86 | CYP1A2 (0.59) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL29538594 | 0.86 | CYP1A2 (0.59) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL254406 | 0.85 | ALDH1A1 (0.56) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL30800630 | 0.85 | ALDH1A1 (0.56) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL16687493 | 0.85 | ALDH1A1 (0.56) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL16284318 | 0.85 | ALDH1A1 (0.56) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL1666013 | 0.84 | CYP1A2 (0.53) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL4353073 | 0.83 | CYP1A2 (0.59) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL888030 | 0.82 | ALDH1A1 (0.53) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL1667854 | 0.82 | CYP1A2 (0.54) | CYP1A2ALDH1A1HSD17B10TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3081612-B1 | PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES | CEMEDINE CO LTD (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-9718999-B2 | Photocurable composition having adhesive properties | CEMEDINE CO., LTD (JP) | 2017-08-01 | — | — | US | disclosed |
| US-20160312089-A1 | PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES | CEMEDINE CO., LTD. (JP) | 2016-10-27 | — | — | US | disclosed |
| EP-3081612-A1 | PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES | Cemedine Co., Ltd. (JP) | 2016-10-19 | — | — | EP | disclosed |
| US-20130123486-A1 | Photogenerated reagents | GAO XIAOLIAN (US) | 2013-05-16 | — | — | US | disclosed |
| US-8076501-B2 | Photogenerated reagents | LC SCIENCES LC | 2011-12-13 | — | — | US | disclosed |
| US-20100137600-A1 | Photogenerated reagents | LC SCIENCES LC | 2010-06-03 | — | — | US | disclosed |
| US-7544829-B2 | Photogenerated reagents | LC SCIENCES LC | 2009-06-09 | — | — | US | disclosed |
| US-20080009630-A1 | Photogenerated reagents | LC SCIENCES LC | 2008-01-10 | — | — | US | disclosed |
| US-7235670-B2 | Photogenerated reagents | Gao, Xiaolian | 2007-06-26 | — | — | US | disclosed |
| EP-0777498-B1 | CONJUGATES MADE OF METAL COMPLEXES AND OLIGONUCLEOTIDES | SCHERING AG (DE) | 2004-04-28 | — | — | EP | disclosed |
| EP-0777485-B1 | 2',5' PHOSPHOROTHIOATE/PHOSPHODIESTER OLIGOADENYLATES AND ANTIVIRAL USES THEREOF | UNIV TEMPLE (US) | 2003-02-19 | — | — | EP | disclosed |
| US-20020077306-A1 | CONJUGATES MADE OF METAL COMPLEXES AND OLIGONUCLEOTIDES, AGENTS CONTAINING THE CONJUGATES, THEIR USE IN RADIODIAGNOSIS AS WELL AS PROCESS FOR THEIR PRODUCTION | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2002-06-20 | — | — | US | disclosed |
| EP-1207909-A2 | METHOD FOR COUPLING MOLECULES | MEDICAL RESEARCH COUNCIL (GB) | 2002-05-29 | — | — | EP | disclosed |
| WO-2001015737-A2 | METHOD FOR COUPLING MOLECULES | MEDICAL RESEARCH COUNCIL (GB) | 2001-03-08 | — | — | WO | disclosed |
| US-5863905-A | GREATLY ENHANCED METABOLIC STABILITY; NONHYDROLYZING; RESISTANCE TO SERUM PHOSPHODIESTERASES; NONTOXIC; INHIBIT OR ACTIVATE RIBONUCLEASE; AIDS, HTLV; HEPATITIS VIRUS; MS; PLANT VIRUSES, E.G. TOBACCO MOSAIC VIRUS; | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1999-01-26 | — | — | US | disclosed |
| EP-0777498-A1 | CONJUGATES MADE OF METAL COMPLEXES AND OLIGONUCLEOTIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-06-11 | — | — | EP | disclosed |
| EP-0770146-A1 | CONJUGATES OF METAL COMPLEXES AND OLIGONUCLEOTIDES, WHICH SPECIFICALLY BOND TO SPECIFIC TARGET STRUCTURES, AGENTS CONTAINING THESE CONJUGATES, THEIR USE IN NMR DIAGNOSIS AS WELL AS PROCESS FOR THEIR PRODUCTION | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-05-02 | — | — | EP | disclosed |
| WO-1996002274-A1 | CONJUGATES MADE OF METAL COMPLEXES AND OLIGONUCLEOTIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-02-01 | — | — | WO | disclosed |
| WO-1996002669-A1 | CONJUGATES OF METAL COMPLEXES AND OLIGONUCLEOTIDES, WHICH SPECIFICALLY BOND TO SPECIFIC TARGET STRUCTURES, AGENTS CONTAINING THESE CONJUGATES, THEIR USE IN NMR DIAGNOSIS AS WELL AS PROCESS FOR THEIR PRODUCTION | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123486-A1 | Photogenerated reagents | PPOX, PGR, GRHPR | CYP1A2 221/4885ALDH1A1 1813/4885HSD17B10 1059/4885 |
| US-20080009630-A1 | Photogenerated reagents | PPOX, PGR, GRHPR | CYP1A2 221/4885ALDH1A1 1813/4885HSD17B10 1059/4885 |
| US-20020077306-A1 | CONJUGATES MADE OF METAL COMPLEXES AND OLIGONUCLEOTIDES, AGENTS CONTAINING THE CONJUGATES, THEIR USE IN RADIODIAGNOSIS AS WELL AS PROCESS FOR THEIR PRODUCTION | DCLRE1B, RNASE1, DCLRE1A | CYP1A2 4573/4885ALDH1A1 2735/4885HSD17B10 3614/4885 |
| US-20100137600-A1 | Photogenerated reagents | PPOX, PGR, GRHPR | CYP1A2 221/4885ALDH1A1 1813/4885HSD17B10 1059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.